1. Spinal neurons exhibit a surprising capacity to learn and a hidden vulnerability when freed from the brain’s control

   • James W. Grau
   • Michelle A. Hook

   Invited Commentary Pages: 177 - 180

2. Web Alert

   News Pages: 181 - 182

3. Unraveling molecular markers of biologic therapies in glioma

   • Andrew B. Lassman
   • Lauren E. Abrey

   Clinical Trials Report Pages: 185 - 186

4. Stroke in cancer patients

   • Teri Nguyen
   • Lisa M. DeAngelis

   OriginalPaper Pages: 187 - 192

5. Paraneoplastic neurologic syndromes

   • Steven Vernino

   OriginalPaper Pages: 193 - 199

6. Medulloblastoma: Therapy and biologic considerations

   • Timothy R. Gershon
   • Orren J. Becher

   OriginalPaper Pages: 200 - 206

7. Image-guided intensity-modulated radiation therapy of spine tumors

   • Yoshiya Yamada
   • Michael Lovelock
   • Mark H. Bilsky

   OriginalPaper Pages: 207 - 211

8. Recent advances in the treatment of oligodendrogliomas

   • Mark Agulnik
   • Warren P. Mason

   OriginalPaper Pages: 212 - 217

9. Neurologic toxicities of cancer therapies

   • Robert Cavaliere
   • David Schiff

   OriginalPaper Pages: 218 - 226

10. Remyelination strategies: New advancements toward a regenerative treatment in multiple sclerosis

    • Martin Stangel
    • Corinna Trebst

    OriginalPaper Pages: 229 - 235

11. Demyelinating disorders: Update on transverse myelitis

    • Chitra Krishnan
    • Adam I. Kaplin
    • Sanjay C. Keswani

    OriginalPaper Pages: 236 - 243

12. Role of mitochondria in multiple sclerosis

    • Bernadette Kalman

    OriginalPaper Pages: 244 - 252

13. Progressive multifocal leukoencephalopathy and multiple sclerosis: Lessons from natalizumab

    • Annette Langer-Gould
    • Lawrence Steinman

    OriginalPaper Pages: 253 - 258

14. Complementary and alternative medicine: Is there a role in multiple sclerosis?

    • Vijayshree Yadav
    • Dennis Bourdette

    OriginalPaper Pages: 259 - 267